» Articles » PMID: 38473800

Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Mar 13
PMID 38473800
Authors
Affiliations
Soon will be listed here.
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder, but kidneys are not the only organs involved in this systemic disorder. Individuals with the condition may display additional manifestations beyond the renal system, involving the liver, pancreas, and brain in the context of cystic manifestations, while involving the vascular system, gastrointestinal tract, bones, and cardiac valves in the context of non-cystic manifestations. Despite kidney involvement remaining the main feature of the disease, thanks to longer survival, early diagnosis, and better management of kidney-related problems, a new wave of complications must be faced by clinicians who treated patients with ADPKD. Involvement of the liver represents the most prevalent extrarenal manifestation and has growing importance in the symptom burden and quality of life. Vascular abnormalities are a key factor for patients' life expectancy and there is still debate whether to screen or not to screen all patients. Arterial hypertension is often the earliest onset symptom among ADPKD patients, leading to frequent cardiovascular complications. Although cardiac valvular abnormalities are a frequent complication, they rarely lead to relevant problems in the clinical history of polycystic patients. One of the newest relevant aspects concerns bone disorders that can exert a considerable influence on the clinical course of these patients. This review aims to provide the "state of the art" among the extrarenal manifestation of ADPKD.

Citing Articles

A miRNA-Based Approach in Autosomal Dominant Polycystic Kidney Disease: Challenges and Insights from Adult to Pediatric Evidence.

Vitulano C, Forcina G, Colosimo S, Frattolillo V, Villani A, Marzuillo P Mol Diagn Ther. 2025; 29(2):183-193.

PMID: 39820940 DOI: 10.1007/s40291-024-00761-7.


Spontaneous Coronary Artery Dissection in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of the Literature.

Milutinovic S, Bell A, Jancic P, Stanojevic D, Borghol A, Mina J J Pers Med. 2024; 14(7).

PMID: 39063956 PMC: 11278354. DOI: 10.3390/jpm14070702.

References
1.
Patch C, Charlton J, Roderick P, Gulliford M . Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study. Am J Kidney Dis. 2011; 57(6):856-62. DOI: 10.1053/j.ajkd.2011.01.023. View

2.
Kuo I . Defining Cardiac Dysfunction in ADPKD. Kidney360. 2023; 4(2):126-127. PMC: 10103198. DOI: 10.34067/KID.0000000000000066. View

3.
Heinonen P, Vuento M, Maunola M, Ala-Houhala I . Ovarian manifestations in women with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2002; 40(3):504-7. DOI: 10.1053/ajkd.2002.34902. View

4.
Qian F, Germino F, Cai Y, Zhang X, Somlo S, Germino G . PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet. 1997; 16(2):179-83. DOI: 10.1038/ng0697-179. View

5.
Arjune S, Grundmann F, Todorova P, Hendrix C, Pfister R, Freyhaus H . Cardiac Manifestations in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single-Center Study. Kidney360. 2023; 4(2):150-161. PMC: 10103268. DOI: 10.34067/KID.0002942022. View